Can Biologic Augmentation Improve Clinical Outcomes Following Microfracture for Symptomatic Cartilage Defects of the Knee? A Systematic Review.

@article{Arshi2018CanBA,
  title={Can Biologic Augmentation Improve Clinical Outcomes Following Microfracture for Symptomatic Cartilage Defects of the Knee? A Systematic Review.},
  author={Armin Arshi and Peter D. Fabricant and Derek E Go and Riley J. Williams and David R. Mcallister and Kristofer J. Jones},
  journal={Cartilage},
  year={2018},
  volume={9 2},
  pages={146-155}
}
Objective To perform a systematic review of clinical outcomes following microfracture augmented with biological adjuvants (MFX+) compared with microfracture (MFX) alone. Design The MEDLINE, Scopus, and Cochrane databases were searched for clinical studies on MFX+ for chondral defects of the knee. Study characteristics and clinical outcome score data were… CONTINUE READING